C hronic pancreatitis is a condition characterised by irreversible destruction and fibrosis of the exocrine parenchyma, leading to exocrine pancreatic insufficiency and progressive endocrine failure leading to diabetes. Alcoholic chronic pancreatitis is the commonest type of chronic pancreatitis seen in the western world, while in the tropics there is a distinct nonalcoholic type of chronic pancreatitis of uncertain aetiology, which is far more common. Several names have been proposed for this type of chronic pancreatitis including tropical chronic pancreatitis (TCP), tropical calcific pancreatitis, juvenile pancreatitis syndrome, Afro-Asian pancreatitis, and fibrocalculous pancreatic diabetes. We prefer to use tropical calcific pancreatitis to describe the early prediabetic stage of the disease and the term fibrocalculous pancreatic diabetes (FCPD), a term introduced by the World Health Organisation (WHO) Study Group report on diabetes, 1 to denote the later, diabetic stage of the syndrome (fig 1) . However both terms are often used interchangeably as they essentially refer to the same disease.
DEFINITION
TCP can be defined as a juvenile form of chronic calcific non-alcoholic pancreatitis prevalent almost exclusively in the developing countries of the tropical world. Some of its distinctive features are younger age at onset, presence of large intraductal calculi, an accelerated course of the disease leading the end points of diabetes and/or steatorrhoea, and a high susceptibility to pancreatic cancer. [2] [3] [4] [5] The differences between TCP and alcoholic chronic pancreatitis are summarised in table 1. 6 
EPIDEMIOLOGY
In 1959, Zuidema first reported a series of patients with pancreatic calculi and clinical features of undernutrition occurring in the lower socioeconomic strata of society. 7 Since then, many reports have been published establishing TCP as a distinct form of chronic pancreatitis that is present in many developing countries in the tropics. [8] [9] [10] [11] The first case of pancreatic calculi from India was reported by Kini in 1937 10 and this was followed by reports of pancreatic calculi observed at postmortem from Vellore in southern India. 11 Reports from several tropical parts of the world 11 including Nigeria, 12 Uganda, 13 other parts of Africa, 14 Brazil, 15 Thailand, 16 Bangladesh, 17 and Sri Lanka 18 have subsequently confirmed the existence of TCP. However, it was after Geevarghese, one of the pioneers in the field, documented one of the largest series in the world from Kerala state in Southern India that TCP attracted international attention. 8 19 Large series of TCP patients have also been reported by a number of workers from various states in India. [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] At the M V Diabetes Specialities Centre, Chennai (formerly Madras), a large referral centre for diabetes in south India, about 50 patients with FCPD are registered annually, which constitutes about 1% of all diabetic patients seen at the centre. 2 Unfortunately most of the available data are clinic based and hence subject to referral bias. There is very little information on the prevalence of TCP in the population. One survey done in Kerala reported a prevalence of 125/100 000 population. 33 However this was done in an area that is endemic for TCP and the frequency is probably much lower in other parts of India. In a recent study from Japan, prevalence of chronic pancreatitis was reported to be 45.4/100 000 population, 34 which is higher than in western countries where it is reported to be approximately 10-15/ 100 000 population with an annual incidence of 3.5-4/ 100 000 population.
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CLINICAL PRESENTATION
TCP patients present with several distinct clinical features. Earlier reports suggested that patients were poor, extremely emaciated, young (over 90% are below 40 years of age at onset), and emphasised the presence of protein calorie malnutrition, bilateral parotid enlargement, distended abdomen, and sometimes with a cyanotic hue of the lips. 8 9 However, recent reports suggest a change in the clinical presentation that may be attributed to improved nutritional status. 21 24 28 We found that while the majority of patients were lean, severe malnutrition was uncommon; many patients were of ideal body weight 28 and an occasional patient even obese. 38 Most of the patients are aged 10-30 years when the diagnosis is made, but onset of TCP in infancy, 39 childhood, 40 and the elderly 41 is not uncommon. The clinical picture of TCP consists of a triad of: N Abdominal pain. N Maldigestion leading to steatorrhoea. N Diabetes.
Abdominal pain
Abdominal pain is the predominant symptom and usually the presenting complaint in 30%-90% of patients in different series. 42 43 The pain is typically very severe, upper abdominal in location, radiates to the back, and is relieved by stooping forward or lying in a prone position. The severity of the pain tends to decrease and it becomes less frequent as the disease progresses and it usually disappears with onset of exocrine insufficiency and/or diabetes. 44 45 Pancreatic calculi In over 90% of patients with TCP, pancreatic calculi may be detected especially in the later stages. 43 46 The calculi are intraductal in location and are seen mostly on the right side of first and second lumbar vertebra on plain abdominal radiography. 19 They may be solitary or multiple, and sometimes the entire pancreas may be studded with calculi ( fig 2) . The stones tend to be large, dense, and rounded with well defined edges in contrast to the small, speckled, ill defined stones in alcoholic chronic pancreatitis. 47 48 Maldigestion/steatorrhoea Patients with severe exocrine pancreatic insufficiency complain of passing bulky, frothy, or frankly oily stools. However, overt steatorrhoea is only present in about 20% of patients with TCP. The low frequency of steatorrhoea is attributed to the low fat intake in the diet. When the fat intake of the diet was experimentally increased to 100 g/day from the average intake of 27 g/day, 76% of TCP patients developed steatorrhoea. 49 
Diabetes
Diabetes is an inevitable consequence of TCP commonly occurring a decade or two after the first episode of abdominal pain. 44 45 Diabetes in TCP is called fibrocalculous pancreatic diabetes (FCPD), which is now classified under the broad category of other specific types both in the American Diabetes Association and the WHO consultation classifications of diabetes. 4 5 In lean and undernourished individuals, the diabetes tends to be more severe and polyuria and polydipsia are the major presenting complaints. In the better nourished patients, the symptoms may be insidious and the diagnosis of FCPD is usually made during investigations for pain in the abdomen. Unless there is a high index of suspicion, the diagnosis is often delayed or missed.
One of the characteristic clinical features of FCPD is that despite requiring insulin for control, patients rarely become ketotic on withdrawal of insulin. This is attributed to the following factors:
1. Partial preservation of beta cell function as shown by Cpeptide studies. [50] [51] [52] [53] 2. Decreased glucagon reserve. 54 3. Reduced supply of non-esterified fatty acid (NEFA), the fuel needed for ketogenesis, due to the loss of subcutaneous tissue. 4. Resistance to subcutaneous adipose tissue lipolysis to epinephrine. 5. Carnitine deficiency, affecting transfer of NEFA across mitochondrial membrane. 44 55 While some studies have shown that patients with FCPD have insulin resistance to a similar degree to that seen in type 2 diabetic patients, 56 others have not found insulin resistance to be a major factor in FCPD. 57 Diabetes is usually very severe with a fasting blood glucose from 11.1-22.2 mmol/l (200-400 mg/dl) and often requires the use of insulin for control. The mean daily insulin dose in a clinic based study was 40¡12 units/day especially when an insulin secretagogue was also used. 57 58 However there is a wide spectrum in the clinical presentation of FCPD with patients requiring only diet/oral drug treatment at one end of the spectrum to others who present with ketosis requiring insulin for survival at the other end ( fig 3) .
PATHOLOGY
TCP is a progressive disease, therefore the pathological findings depend on the stage of the disease at which the specimen is obtained. The pathological changes in TCP are mostly reported from postmortem or surgical specimens and several excellent reviews have been published.
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Gross findings
The size of the pancreas varies inversely with the duration of the disease and can be as small as the little finger in advanced stages of the disease. The surface is nodular. The shape of the gland is distorted with loss of the normal lobular appearance.The gland is usually firm, fibrous, and gritty. However depending on the presence of fibrous tissue, cyst, or stone the consistency may vary in different regions of the pancreas.
The cut section of the pancreas shows the presence of homogenous areas with early to advanced fibrosis and intraductal calculi of varying shapes and sizes with marked dilation of the duct and ductules. Areas of dilation and stenosis may be seen in the same gland. The gland may get displaced from its normal location due to uneven shrinkage and fibrous adhesion. Calculi may vary in size, shape, and colour. The size could range from small sand particles to large stones 4.5 cm long and weighing up to 20 g with the larger ones being located near the head and smaller ones near the tail. The shape of the calculi may be smooth, rounded, or staghorn-like and it is usually incarcerated in the main pancreatic duct or its major branches. Soft stones are formed by non-calcified protein plugs and caseous material. Sections of calcified stones show epithelial debris, fibrin, and mucinous material. Colour of the stones vary from chalky white to dirty white.
Analysis of the stones
Pancreatic calculi are composed of 95.5% calcium carbonate and small amount of calcium phosphate. In some stones, traces of magnesium, urate, and oxalate have also been identified. The calcium carbonate is predominantly the calcite, and rarely the vaterite form, as demonstrated by xray diffraction studies. 62 Calculi have been found to have an amorphous nidus rich in iron, chromium, and nickel and a cryptocrystalline periphery containing a number of trace elements with a predominance of calcium. 63 
Microscopy
Microscopic examination reveals a thickened capsule and extensive intralobular and interlobular fibrosis not limited to any one zone or area. Interlobular fibrosis is characteristic of early cases and focal, segmental, or diffuse fibrosis of more advanced cases. Marked dilatation with periductular fibrosis is seen in the main duct, collecting ducts, and small ductules with denudation of the ductular epithelium and squamous metaplasia in some areas. The characteristic cellular infiltration of the pancreas is composed of lymphocytes and plasma cells, distributed mainly around the ducts. 25 59 Some investigators report that there is virtually no inflammation in TCP and therefore prefer to call this condition as ''tropical calcific pancreatopathy'' rather than ''tropical calcific pancreatitis''. 60 61 Immunohistochemistry Immunohistochemistry has shown paucity of alpha cells and beta cells. 60 64 Immunohistochemistry studies show a decrease in the number of islets in some cases and hyperplasia in others. Nesidioblastosis may also be present in some patients (fig 4) . There is an overall decrease in the percent of insulin and glucagon cells. The decrease in insulin positivity in the islets often correlates with the serum Cpeptide levels and inversely with the duration of diabetes. 64 
AETIOPATHOGENESIS
The exact aetiopathogenetic mechanisms still remain elusive. The following hypotheses have been proposed: 
Malnutrition
The role of undernutrition in the aetiology of TCP has been reviewed in a number of papers. 43 62 This theory is based primarily on the initial observations that TCP affects the poor population of developing nations. It is indeed true that protein calorie malnutrition is present in many patients with TCP. However, recent observations question this hypothesis. 8 28 65-68 The large pockets of malnutrition in many parts of the world compared with the relative low frequency of TCP, for example Ethiopia, 69 suggests that malnutrition by itself is unlikely to have an aetiological role. Further, kwashiorkor seldom leads to permanent pancreatic damage and pancreatic stones are absent even in advanced stages of kwashiorkor. Ironically, Kerala, a state in southern India with the highest literacy and lowest infant mortality rates, has the highest prevalence of TCP. Malnutrition thus could well be the effect rather than the cause of the disease since chronic pancreatitis with consequent malabsorption could itself lead to malnutrition. Also since protein calorie malnutrition is prevalent in many tropical countries, it is likely to be an accompanying factor in many diseases affecting the poor.
Recent studies on monkeys fed on high carbohydrate and low protein diet reported that they develop inflammatory and vascular changes in the pancreas and the heart and that the lesions mimicked those found in TCP. 70 However, pancreatic calculi or diabetes were not observed in the study. Thus the relevance of these findings to TCP is unclear. The consensus therefore is that protein calorie malnutrition cannot be considered as the main aetiological factor of TCP.
Cassava toxicity (cyanogen toxicity) Cassava (tapioca, Manihot esculenta) is a tuber consumed as a staple food by poor people in some parts of the world including Kerala. Cassava is known to contain cyanogenic glycosides such as linamarin and lotaustralin. Cyanide is normally detoxified in the body by conversion to thiocyanate, but this detoxification requires sulphur. In those with malnutrition, sulphur containing amino acids like methionine and cystine are deficient and the theory is that when these patients consume cassava, they develop pancreatitis leading to TCP.
McMillan and Geevarghese reported that rats develop transient hyperglycaemia on ingestion of cyanide which led them to conclude that there is role of cyanide in the aetiopathogenesis of tropical chronic pancreatitis. 71 However potassium cyanide was used in these experiments and not cassava. Moreover, none of the rats developed permanent diabetes or chronic pancreatitits. Recent epidemiological and experimental studies further question the cassava hypothesis. TCP is prevalent in many parts of India and Africa where cassava is not consumed and TCP is also not seen in a rural West African population consuming a high cassava diet. 72 Short term experimental feeding of cassava in animal models has produced conflicting results. [73] [74] [75] A recent study on rats fed cassava diets for up to one year did not produce either pancreatitis or diabetes. 76 Thus the cassava hypothesis lacks experimental support.
Familial aggregation TCP sometimes affects many members of the same family 51 77-79 and one study 77 found 17 families with two or more affected members. In a more recent study, familial aggregation was seen in 8% of TCP patients. 78 In some families, there was evidence of vertical transmission of TCP from the parents to the offspring, while in others, there was horizontal distribution of the disease among siblings. Familial aggregation suggests, but does not necessarily prove, a hereditary aetiology for TCP, since several family members could be exposed to the same toxic or other environmental factors.
Genetic factors
We looked for a genetic basis for this disease and in our first report suggested that FCPD might share common susceptibility genes with type 1 and type 2 diabetes. 79 The islet regenerating gene (Reg gene) has been implicated in the pathogenesis of temperate zone pancreatitis. We therefore studied the association of FCPD with possible sequence variants of the Reg gene by RFLP analysis and found that mutation in the coding region of the Reg gene was unlikely to be the cause of FCPD. 80 A recent report from Thailand also did not find any mutations of Reg 1 alpha and Reg I beta genes in FCPD patients. 81 The molecular basis for hereditary pancreatitis has been attributed to mutations in exons 2 and 3 of the trypsinogen gene. 82 83 We looked at these genes in our patients but found that FCPD was not linked to common mutations in the trypsinogen gene. 84 SPINK 1 is a potent protease inhibitor and is considered to be a major protective mechanism in preventing inappropriate activation of pancreatic enzyme cascade by inhibiting up to 20% of trypsin activity. 85 Since the inhibitory molecule provides the first line of defence against premature activation of trypsinogen inside the pancreas, it has recently attracted a lot of attention as a possible cause of chronic pancreatitis. Recently an association of hereditary pancreatitis has been shown with the SPINK 1 (serine protease inhibitor, Kazal type 1) gene. 85 The association between the SPINK gene and TCP has now been reported by a number of groups. 3 4 86-90 Since all the above studies on TCP and others on other forms of chronic pancreatitis have shown a strong association with this gene, 91 it is likely that this could be at least one of the genes predisposing to chronic pancreatitis in general and TCP in particular.
Micronutrient deficiency and oxidant stress
Chronic pancreatitis in white people has been linked to ''heightened oxidative detoxification reactions'' induced by cytochrome P450-1 within the pancreas and/or liver. 92 93 It is possible that several factors, including chronic induction of the cytochrome P450-1 subfamily of mono-oxygenase by xenobiotics (cigarettes, alcohol, occupational chemicals, dietary corn oil, and so forth) may be involved. Theophylline clearance (a measure of cytochrome P450-I activity in vivo) is faster in TCP subjects compared with controls 94 suggesting a role of oxidant stress in causation of TCP. Studies on the antioxidant status of our TCP patients showed low levels of vitamin C and b-carotene 95 and this may well tilt the balance in favour of oxidant stress. Malnutrition induces a state of defective ability to scavenge free radicals, which could enhance the susceptibility for organ damage. Braganza et al suggested that free radical injury occurs in patients with alcoholic chronic pancreatitis as well as TCP. 96 However, the free radical hypothesis is by no means proven and certainly merits further studies.
INVESTIGATIONS
Diagnosis of TCP is made by establishing evidence of chronic pancreatitis in patients who have the typical clinical features described earlier. If pancreatic calculi are present on plain abdominal radiography, the diagnosis is straightforward. However, calculi develop after several years of abdominal pain and about 10% of patients do not develop calculi. Hence the need for other diagnostic markers. Unfortunately, there are still no sensitive and specific non-invasive blood or urine tests to diagnose early stages of chronic pancreatitis. Even in the developed nations of the world, the diagnosis of chronic pancreatitis in adults or children is often elusive and made very late, only after ductal changes or calculi develop. As in other types of chronic pancreatitis, the diagnosis of TCP is seldom made in the early stages of the disease.
The investigation for a suspected case of TCP without pancreatic calculi is as follows: By ultrasonography of the abdomen it is possible to evaluate the size of the pancreas and also confirm intraductal location of calculi and the degree of fibrous.
97 Figure 5 shows the typical ultrasound appearance with dilated pancreatic ducts with intraductal calculi. Imaging of smaller stones and diagnosis of pseudocyst is better on computed tomography. 98 Endoscopic retrograde cholangiopancreatography (ERCP) studies help to confirm ductal dilatation particularly in the non-calcific causes of TCP. ERCP may show ductal tortuosity and dilation (fig 6) , stenosis, obstruction, cyst formation, and the presence of calculi in the main pancreatic duct, side branches, and ductules. 99 Endoscopic ultrasonography is an exciting new tool for diagnosis of chronic pancreatitis, especially at a relatively early stage. Comparisons with histology have shown the sensitivity and specificity of endoscopic ultrasonography to be 85% and 67% respectively. 100 However more studies are required before accepting it as a standard diagnostic procedure for chronic pancreatitis.
EXOCRINE PANCREATIC FUNCTION
Exocrine pancreatic function in TCP has been studied by many workers using a variety of tests. Serum immunoreactive trypsin measurements have shown a spectrum of pancreatic involvement. In advanced stages of the disease, there is marked reduction of trypsin level while in early stages it may be subnormal or even elevated due to acute pancreatitis. 101 102 When Lundh meal tests were performed, 93% of the TCP patients with calcification were reported to have low tryptic activity compared with 27% of the noncalcific variety. 103 Secretin-pancreazymin tests revealed gross reduction in volume, bicarbonate, trypsin, and lipase content of the pancreatic secretion. 77 The lactoferrin level of the pancreatic juice was found to be considerably higher in both normal controls and TCP subjects from India compared with their respective European counterparts. There are several reports using faecal chymotrypsin as a screening test for evaluating exocrine pancreatic function in TCP patients. 101 104 105 We screened three groups of diabetic patients with FCPD and type 1 and type 2 diabetes and found that exocrine pancreatic insufficiency as shown by low faecal chymotrypsin levels (defined as ,5.8 units/g of faecal mass) was present in 87.5% of patients with FCPD, 23.5% with type 1 diabetes, and 4.5% with type 2 diabetes. 104 Low sensitivity is the only drawback with faecal chymotrypsin as it may not detect many mild cases of chronic pancreatitis, although its specificity is quite high. The usefulness of faecal chymotrypsin was compared with another tubeless test, namely the N-benzoyl L-tyrosyl-para-aminobenzoic acid (BT-PABA) test. 106 We found that although the faecal chymotrypsin test has a slightly lower sensitivity, it is simpler and considerably cheaper than the PABA test. We have also shown that the BT-PABA/p-aminosalicylic acid is an excellent test to diagnose TCP as it has a very high sensitivity and specificity. 107 
ENDOCRINE FUNCTION
Studies on C-peptide assay (a marker of pancreatic beta cell function) in FCPD patients indicate partial preservation of pancreatic beta cell function, in contrast to classical type 1 patients who have negligible beta cell reserve. Yajnik et al measured beta cell function in TCP patients with different degrees of glucose tolerance and found that plasma C-peptide concentrations were normal in those with normal or mildly impaired glucose tolerance. 108 In the diabetic group, the Cpeptide levels were scattered; they were severely diminished in some while in the rest some beta cell reserve was present.
Plasma glucagon responses have been shown to be defective in patients with FCPD. 54 In response to a glucose load, plasma glucagon levels rose sharply in subjects with primary forms of diabetes, whereas glucagon response was absent in the FCPD group.
COMPLICATIONS
Complications due to chronic pancreatitis Complications due to chronic pancreatitis include pseudocysts, pancreatic abscesses, and ascites. Obstructive jaundice may also be occasionally seen, which can be due to common bile duct obstruction or associated carcinoma of the pancreas.
Pancreatic cancer is the most sinister complication of TCP. The risk of developing pancreatic cancer among patients with temperate zone chronic pancreatitis has been estimated to be 16.5-fold higher than age matched controls. 109 In TCP patients the risk is probably higher. In one study, 185 TCP patients were followed up for an average of 4.5 years to assess the risk of pancreatic cancer. During this period, 34 patients died from all causes, and six deaths (25%) were due to pancreatic cancer. When compared with the background pancreatic cancer rate (Madras Cancer Registry), the relative risk for pancreatic cancer in patients with TCP was 100 (95% confidence interval 37 to 218). 110 Augustine and Ramesh have also reported an increased risk of pancreatic carcinoma in TCP. 111 While there are no direct comparisons with temperate zone pancreatitis, it appears that the risk of developing pancreatic cancer is higher in TCP than in alcoholic chronic pancreatitis. The only other type of pancreatitis that is highly prone to malignancy is hereditary pancreatitis where the risk ratio is 53 compared with the general population. 112 The duration of exposure to inflammation seems to be the major factor involved in the transition to a malignant condition in chronic pancreatitis and smoking remains the strongest risk factor that is amenable to preventive intervention 113 in temperate zone pancreatitis, while the risk factors for cancer in TCP remain unknown.
Complications related to diabetes It was earlier believed that patients with FCPD do not develop long term complications of diabetes. This belief was based mainly on the assumption that being a secondary form of diabetes, patients with FCPD do not live long enough to develop specific diabetes related complications, which normally set in only after 10-15 years of diabetes. However, a series of studies from our group and others have shown that both microvascular and macrovascular complications do occur in patients with FCPD.
Rema et al reported advanced retinopathy in FCPD patients, 114 which has been confirmed by others. 115 Nephropathy was seen in 8.9% of our FCPD patients. Renal failure due to diabetic nephropathy has also been reported in other forms of pancreatic diabetes. 116 Peripheral neuropathy 117 and autonomic neuropathy 118 119 have also been reported in those with FCPD.
Macrovascular complications are, however, rare in FCPD. This is believed to be due to three reasons: the patients are young, lean, and have low lipid levels. However, ischaemic heart disease, 120 cerebrovascular accidents, 121 122 and peripheral vascular disease have occasionally been reported. 123 124 Recently we did a comparative study on the prevalence of long term complications of diabetes in a large group of FCPD patients and a group of type 2 diabetic patients matched for age, sex, and duration of diabetes. The prevalence of all microvascular complications was found to be equal in both groups but macrovascular complications, particularly coronary heart disease, was significantly lower in the FCPD group. 125 
NATURAL HISTORY
Abdominal pain usually is the first symptom to manifest in the natural history of TCP. After prolonged periods varying from a few months to several decades, pancreatic calculi may be diagnosed by routine abdominal radiography. Until this point, both endocrine and exocrine pancreatic function of the subject may be found to be normal. After some months to years, glucose intolerance and/or exocrine pancreatic dysfunction may set in. Although this is the classical presentation, the first sign of the disease may be detection of pancreatic calculi, diabetes, or steatorrhoea. It is believed by most workers in the field that FCPD is the logical end point of TCP-that is, that TCP is the prediabetic stage of FCPD. However, recent reports from Bangladesh have suggested that TCP and FCPD are two different entities. 126 127 Based on long term follow up of large numbers of patients, we believe that FCPD is indeed the later diabetic stage of TCP for the following reasons:
1. TCP patients are younger than FCPD patients. 128 2. TCP patients are also seen at the impaired glucose tolerance stage, 128 129 which is considered to be a prediabetic stage. 3. The presence of SPINK 1 mutations in both TCP and FCPD, 89 suggests a common genetic basis. 4. In a recent longitudinal follow up study we found that almost 50% of the TCP subjects without diabetes at baseline developed diabetes after a mean follow up of about seven years. The incidence of diabetes in the study group was 6.6 per 100 follow up years (Mohan et al, manuscript in preparation).
LONG TERM SURVIVAL ANALYSIS
In the 1960s and 70s, it was reported that TCP patients develop abdominal pain in childhood, diabetes by adolescence, and die of complications of diabetes such as chronic pancreatitis in early adulthood or in the prime of their life. 8 Today TCP patients survive much longer, perhaps due to improved nutrition and better control of diabetes. We analysed the survival time of a cohort of 370 FCPD patients, taking the date of first occurrence of abdominal pain and the time of onset of diabetes as the two reference points. 130 About 80% of patients were alive 35 years after the first episode of abdominal pain. The mean survival time after the diagnosis of diabetes was 25 years. The majority of deaths were associated with diabetes related causes, with diabetic nephropathy accounting for 40%. Severe infections, pancreatic cancer, and pancreatitis related causes also contribute to the mortality of FCPD patients. However, the overall prognosis of these patients seems to have considerably improved during the last two to three decades.
HETEROGENEITY OF TCP
As described in earlier sessions, TCP is a highly variable (heterogenous) condition, in contrast to the earlier descriptions of the disease made three decades ago. 8 19 Table 2 summarises the evidence for the heterogeneity which is seen with respect to the clinical, biochemical, ERCP, and histopathological features of TCP.
MANAGEMENT
Abdominal pain
Analgesics Non-opioid analgesics should be the first choice and opioids should be avoided wherever possible for fear of addiction. Opioids may be considered for severe intractable episodes of pain which is very difficult to manage with non-opioids.
Role of pancreatic enzyme supplements
Pancreatic enzyme supplementation has been used traditionally to decrease the pain in all types of chronic pancreatitis because suppression of pancreatic secretion reduces intraductal pressure. Owyang et al reported that intraduodenal infusion of trypsin decreases pancreatic exocrine secretion through suppression of cholycystokinin, 131 but other studies do not support these findings. 132 133 The evidence for use of pancreatic enzyme in pain relief is, however, controversial with some trials showing benefit [134] [135] [136] and others no benefit. 137 138 One of the possible reasons for the lack of benefit may be that the enteric coated enzyme preparations do not get released in the duodenum and hence are not capable of activating the negative feedback mechanism. The present consensus is that pancreatic enzyme supplement may be used as an initial treatment modality for relief of pain. 139 Preparations used should contain large amount of protease (.25000 USP units per tablet) and be given in a dosage of four to eight capsules or tablets four times daily. 140 
Antioxidants
Uden et al reported that antioxidants supplementation significantly decreased analgesic requirement in patients with alcoholic chronic pancreatitis. 141 However the study population was heterogeneous and antioxidants and placebo tablets were not identical in their study. Antioxidants supplementation have also been shown to decrease pain in another recent study of TCP patients. 142 Further studies are required for confirming the efficacy of antioxidants.
Steatorrhoea
Malabsorption resulting in steatorrhoea can be managed effectively by low fat diet. We have earlier reported that pancreatic enzymes supplementation help to reduce steatorrhoea and also improve the quality of life. 143 
Diabetes
The principles of management of diabetes remains the same in FCPD as in other types of diabetes except that a more liberal calorie and protein intake may be advised because of the features of undernutrition and leanness. Oral hypoglycaemic agents may be useful in cases with mild diabetes and relatively early in the course of the disease. The majority of patients, however, need insulin for control of diabetes and to improve their general health and sense of wellbeing.
SURGERY
Often, the abdominal pain can be intractable and difficult to manage. When there is no response to medical treatment, surgical intervention is indicated. Various surgical interventions have been tried with fairly good results. 144 145 Many of these procedures are beneficial with respect to alleviation alteration of pain, although some patients may experience a relapse. There are some reports which suggest that after surgery the mean daily insulin requirement may decrease. 20 145 146 These changes are usually transient and the N Steatorrhoea:
-Pancreatic enzyme supplements.
N Diabetes:
-Oral hypoglycaemic agents for early cases.
-Insulin is needed for majority of patients.
diabetic status appears to be largely unaffected by surgery. There is, however, improvement of general health and quality of life, particularly in those with severe intractable pain. The usual surgical procedures used are ductal decompression and drainage techniques like side to side pancreaticojejunostomy (Peustow's procedure) or distal pancreaticojejunostomy (Duval's procedure). 147 Ablative procedures like partial or subtotal pancreatectomy are used in those with intractable pain. 147 Recurrent pain after drainage procedures has often been reported. Stenosis of the anastomosis, retained calculi causing cysts or abscesses, and internal postoperative herniations, sometimes a twisting of the Roux loop used for the pancreatojejunal anastomosis, are some of the causes identified for recurring pain. Pancreatic tumour, however, is the most important condition to be excluded in any patient with persistent or recurrent pain after a drainage procedure.
Extracorporeal shock wave lithotripsy and stone dissolution and endoscopic stone removal are often successful, but the mere removal of stones may not guarantee relief of pain.
FUTURE PERSPECTIVES
TCP is a unique tropical form of chronic pancreatitis seen exclusively in some tropical countries of the world. The prognosis of TCP patients has improved in the last two to three decades and the understanding of the natural history of TCP is also beginning to evolve but its aetiopathogenesis continues to be elusive. Future studies should explore the pathogenetic mechanisms that could pave the way for prevention of this condition. Early diagnosis and newer therapeutic approaches could help to ensure better survival and prognosis of patients with TCP. 
